Literature DB >> 17963088

Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography.

K Nassenstein1, P Veit-Haibach, H Stergar, A Gutzeit, L Freudenberg, H Kuehl, M Fischer, J Barkhausen, A Bockisch, G Antoch.   

Abstract

BACKGROUND: Identification of primary tumor in patients with cervical lymph node metastasis of unknown primary (MUO) has a great impact on therapy approach and potentially on patient prognosis.
PURPOSE: To assess the diagnostic accuracy of combined positron emission tomography(PET)/computer tomography (CT) for primary tumor detection in cervical metastases of unknown origin compared to PET, CT, and PET+CT side-by-side evaluation.
MATERIAL AND METHODS: 39 consecutive patients (eight women, 31 men; mean age 59.9 ± 11.2 years) with MUO were enrolled in this study. PET/CT images were obtained 1 hour after injection of 350 MBq of fluorodeoxyglucose. Oral and intravenous contrast agents were administered in all patients to ensure diagnostic CT data. Fused PET/CT data were evaluated for primary tumor detection. Diagnostic accuracy was calculated and compared with CT alone, PET alone, and side-by-side PET+CT evaluation.Statistical analysis of differences in diagnostic performance between the different imaging procedures was based on the McNemar test.
RESULTS: Fused PET/CT depicted the primary tumor in 11 of 39 (28%) patients. In 28(72%) patients, the primary tumor remained occult. CT revealed the primary in five(13%), PET alone in 10 (26%), and side-by-side evaluation of PET+CT in 10 (26%) of 39 patients. Statistical analysis showed no significant differences between the imaging modalities.
CONCLUSION: PET, side-by-side PET+CT, and PET/CT revealed similar detection rates for primary tumors in cervical MUO patients. Therefore, cervical metastases of an unknown primary may be assessed with either of these imaging modalities. Detection rates with CT were substantially lower. Thus, inclusion of functional data for assessment of cervical MUO patients must be recommended.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963088     DOI: 10.1080/02841850701581768

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  15 in total

Review 1.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

Review 2.  [Importance of nuclear medicine diagnostics in CUP syndrome].

Authors:  M C Winter; U Haberkorn; C Kratochwil
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

3.  PET/MRI and PET/CT in follow-up of head and neck cancer patients.

Authors:  Marcelo A Queiroz; Martin Hüllner; Felix Kuhn; Gerhardt Huber; Christian Meerwein; Spyros Kollias; Gustav von Schulthess; Patrick Veit-Haibach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-28       Impact factor: 9.236

4.  The Role of 18 FDG PET-CT in Evaluation of Unknown Primary Tumours.

Authors:  N K Saidha; M Ganguly; Harkirat Singh Sidhu; Samir Gupta
Journal:  Indian J Surg Oncol       Date:  2013-03-09

5.  Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.

Authors:  R M Subramaniam; M Truong; P Peller; O Sakai; G Mercier
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-12       Impact factor: 3.825

6.  Angiosarcoma of the scalp diagnosed by the presence of neck inflammation: a case report.

Authors:  Rei Karube; Hiroyoshi Sasaki; Keiji Shinozuka; Yasuhiro Fujisawa; Toru Yanagawa; Kenji Yamagata; Kojiro Onizawa; Fujio Otsuka; Hiroki Bukawa
Journal:  Int J Oral Sci       Date:  2012-06-15       Impact factor: 6.344

Review 7.  Cancers of unknown primary origin: current perspectives and future therapeutic strategies.

Authors:  Giulia Maria Stella; Rebecca Senetta; Adele Cassenti; Margherita Ronco; Paola Cassoni
Journal:  J Transl Med       Date:  2012-01-24       Impact factor: 5.531

8.  Diagnosis of Bilateral Tonsil Cancers via Staging PET/CT: Case Report and Review.

Authors:  Edward M Mannina; Sunanda M Pejavar; Christine M Glastonbury; Annemieke van Zante; Steven J Wang; Sue S Yom
Journal:  Int J Otolaryngol       Date:  2011-07-14

Review 9.  FDG PET/CT in carcinoma of unknown primary.

Authors:  Thomas C Kwee; Sandip Basu; Gang Cheng; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236

10.  Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.